• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DAVOL INC., SUB. C.R. BARD, INC. -1213643 VENTRIO MESH; SURGICAL MESH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DAVOL INC., SUB. C.R. BARD, INC. -1213643 VENTRIO MESH; SURGICAL MESH Back to Search Results
Catalog Number 0010218
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Bacterial Infection (1735); Necrosis (1971); Seroma (2069); Hernia (2240)
Event Date 06/19/2015
Event Type  Injury  
Manufacturer Narrative
As reported, about 20 months post-implant of bard/davol ventrio mesh, the patient was diagnosed with hernia recurrence and underwent surgical intervention with implant of a second mesh and without action reported to have been taken in regards to the mesh implanted in 2013.The clinician has assessed the patient¿s postoperative course as being ¿possibly¿ related to the study device and possibly related to the procedure, however, based on the information provided, no conclusion can be made.Hernia recurrence is a known inherent risk of surgery.The instructions-for-use supplied with the device lists hernia recurrence as a possible complication.As reported 5 years after the implant of the second mesh, the patient diagnosed with a seroma and necrosis which appears to have progressed into infected mesh, which resulted in at least partial explant of both implanted mesh.The cause of the seroma an necrosis can't be determined.Mesh infection and seroma are known inherent risk of hernia repair surgery.The instructions-for-use, supplied with the device lists infection and seroma as possible complications.In regards to the infection, the warning section of the ifu states "if an infection develops, treat the infection aggressively.Consideration should be given regarding the need to remove the mesh.An unresolved infection may require removal of the device." this mdr represents the 2013 implanted ventrio mesh (device #1).Additional mdr was submitted to represent the 2015 implanted ventrio mesh (device #2).The information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
Alleged per clinical trial dvl-he-020: on (b)(6) 2013, the patient underwent multi-recurrent open ventral incisional hernia repair, during which a bard/davol ventrio hernia patch (device #1) was placed.Fascia and full skin closure was achieved.(b)(6) 2015, patient experienced incarcerated recurrent incisional hernia.(b)(6) 2015 patient admitted to the hospital.The recurrence resulted in reoperation.Patient underwent open ventral incisional hernia repair, during which a bard/davol ventrio hernia patch was placed (device 2).As reported, no action was taken related to the previously implanted mesh (device 1).The patient was discharged to home on (b)(6) 2015.The ae (recurrence ¿ device 1) is clinically assessed to be serious and possibly related to the study device and possibly related to the procedure.(b)(6) 2019, a culture was obtained the culture tested positive for bacterial infection as gordonia.(b)(6) 2020, patient developed chronic nonhealing abdominal wall with soft tissue necrosis and seroma (ae 2).The reported ae resulted in reoperation and partially removal of both mesh.(b)(6) 2020, patient underwent additional surgical intervention, which included additional partial explant of both mesh, related to ¿chronic mesh infection¿ (ae 2).Ae 2 is clinically assessed to be definitely related to the study devices and definitely related to the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENTRIO MESH
Type of Device
SURGICAL MESH
Manufacturer (Section D)
DAVOL INC., SUB. C.R. BARD, INC. -1213643
100 crossings blvd.
warwick RI 02886
Manufacturer (Section G)
BARD SHANNON LIMITED -3005636544
san geronimo industrial park
lot #1, road #3, km 79.7
humacao PR 00791
Manufacturer Contact
andrew topoulos
100 crossings blvd.
warwick, RI 02886
8005566756
MDR Report Key14497375
MDR Text Key293356827
Report Number1213643-2022-00338
Device Sequence Number1
Product Code FTL
UDI-Device Identifier00801741016455
UDI-Public(01)00801741016455
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K100229
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Study,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 05/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/28/2015
Device Catalogue Number0010218
Device Lot NumberHUWG0536
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/28/2022
Initial Date FDA Received05/25/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age60 YR
Patient SexMale
-
-